POTENT, ORALLY-ACTIVE CARBOXYLATE REPLACEMENT ANALOGS OF THE ENDOTHELIN RECEPTOR ANTAGONIST L-749,329

被引:0
|
作者
FITCH, KJ
WALSH, TF
TOUPENCE, RB
WILLIAMS, DL
NOLAN, NA
OBRIEN, JA
PETTIBONE, DJ
KIVLIGHN, SD
KRAUSE, SM
CLAYTON, FC
ZINGARO, GJ
SIEGL, PKS
GREENLEE, WJ
机构
[1] MERCK SHARP & DOHME RES LABS,DEPT PHARMACOL,RAHWAY,NJ 07065
[2] MERCK SHARP & DOHME RES LABS,DEPT EXPLORATORY CHEM,RAHWAY,NJ 07065
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:162 / MEDI
相关论文
共 50 条
  • [1] THE DISCOVERY OF L-749,329, A HIGHLY POTENT, ORALLY-ACTIVE ANTAGONIST OF ENDOTHELIN RECEPTORS
    WALSH, TF
    FITCH, KJ
    CHAKRAVARTY, PK
    WILLIAMS, DL
    MURPHY, KA
    NOLAN, NA
    OBRIEN, JA
    LIS, EV
    PETTIBONE, DJ
    KIVLIGHN, SD
    GABEL, RA
    ZINGARO, GJ
    KRAUSE, SM
    SIEGL, PKS
    CLINESCHMIDT, BV
    GREENLEE, WJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 145 - MEDI
  • [2] Effects of L-749,329, an ETA/ETB endothelin receptor antagonist, in a porcine coronary artery injury model of vascular restenosis
    Huckle, WR
    Drag, MD
    Acker, WR
    Powers, M
    McFall, RC
    Holder, DJ
    Walsh, TF
    Schwartz, RS
    Greenlee, WJ
    Johnson, RG
    CIRCULATION, 2001, 103 (14) : 1899 - 1905
  • [3] PHARMACOLOGICAL CHARACTERIZATION OF BOSENTAN, A NEW POTENT ORALLY-ACTIVE NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST
    CLOZEL, M
    BREU, V
    GRAY, GA
    KALINA, B
    LOFFLER, BM
    BURRI, K
    CASSAL, JM
    HIRTH, G
    MULLER, M
    NEIDHART, W
    RAMUZ, H
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 270 (01): : 228 - 235
  • [4] Pharmacology of J-104,132, a potent, orally-active, mixed ETA/ETB endothelin receptor antagonist
    Nishikibe, M
    Ishikawa, K
    Fukuroda, T
    Ohta, H
    Kanoh, T
    Ozaki, S
    Noguchi, K
    Saito, M
    Uehara, S
    Williams, D
    Kivlighn, S
    Krause, S
    Gabel, R
    Zingaro, G
    Nolan, N
    O'Brien, J
    Clayton, F
    Lynch, J
    Pettibone, D
    Siegl, P
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R511 - R511
  • [5] PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN REVEALED BY THE 1ST ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST
    CLOZEL, M
    BREU, V
    BURRI, K
    CASSAL, JM
    FISCHLI, W
    GRAY, GA
    HIRTH, G
    LOFFLER, BM
    MULLER, M
    NEIDHART, W
    RAMUZ, H
    NATURE, 1993, 365 (6448) : 759 - 761
  • [6] DESIGN, SYNTHESIS AND EVALUATION OF THE POTENT, ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST L-734,217
    DUGGAN, ME
    NAYLOROLSEN, AM
    PERKINS, JJ
    ANDERSON, PS
    CHANG, CTC
    COOK, JJ
    GOULD, RJ
    IHLE, NC
    HARTMAN, GD
    LYNCH, JJ
    LYNCH, RJ
    MANNO, PD
    SCHAFFER, LW
    SMITH, RL
    BEDNAR, B
    BEDNAR, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 2 - MEDI
  • [7] PROTECTION FROM PULMONARY-HYPERTENSION WITH AN ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST IN HYPOXIC RATS
    EDDAHIBI, S
    RAFFESTIN, B
    CLOZEL, M
    LEVAME, M
    ADNOT, S
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 268 (02): : H828 - H835
  • [8] PULMONARY-HYPERTENSION IS DECREASED BY AN ORALLY-ACTIVE ENDOTHELIN-A ANTAGONIST
    RUMSEY, WL
    BERTELSEN, DL
    ABBOTT, BM
    MALLAMACI, MA
    BIALECKI, RA
    CIRCULATION, 1995, 92 (08) : 2052 - 2052
  • [9] THE DISCOVERY OF L-699,392, A NOVEL POTENT AND ORALLY-ACTIVE LEUKOTRIENE D-4 RECEPTOR ANTAGONIST
    LABELLE, M
    BELLEY, M
    CHAMPION, E
    GORDON, R
    HOOGSTEEN, K
    JONES, TR
    LEBLANC, Y
    LORD, A
    MCAULIFFE, M
    MCFARLANE, C
    MASSON, P
    METTERS, KM
    NICOLLGRIFFITH, D
    OUIMET, N
    PIECHUTA, H
    ROCHETTE, C
    SAWYER, N
    XIANG, YB
    YERGEY, J
    FORDHUTCHINSON, AW
    PICKETT, CB
    ZAMBONI, RJ
    YOUNG, RN
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (03) : 463 - 468
  • [10] MK 287 - A POTENT, SPECIFIC, AND ORALLY-ACTIVE RECEPTOR ANTAGONIST OF PLATELET-ACTIVATING-FACTOR
    HWANG, SB
    LAM, MH
    SZALKOWSKI, DM
    MACINTYRE, DE
    BACH, TJ
    LUELL, S
    MEUER, R
    SAHOO, SP
    ALBERTS, AW
    CHABALA, JC
    JOURNAL OF LIPID MEDIATORS, 1993, 7 (02): : 115 - 134